Changeflow GovPing Government & Legislation National Health (Listed Drugs on F1 or F2) Dete...
Routine Rule Amended Final

National Health (Listed Drugs on F1 or F2) Determination 2021

Email

Summary

The Australian Department of Health, Disability and Ageing has issued the National Health (Listed Drugs on F1 or F2) Determination 2021 under the National Health Act 1953. This legislative instrument determines which drugs are listed on Formulary F1 and Formulary F2 for purposes of the Pharmaceutical Benefits Scheme. Schedule 1 lists drugs on F1 and Schedule 2 lists drugs on F2. The instrument has been amended since its original making and the latest version is in force.

Published by DoH (AU) on legislation.gov.au . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The Determination establishes which drugs are listed on Formulary F1 and Formulary F2 under the National Health Act 1953. The instrument contains definitions, provisions for drugs on each formulary, and two schedules listing the specific drugs. This classification affects which medicines are available under the Pharmaceutical Benefits Scheme and at what subsidy level.

Pharmaceutical manufacturers seeking PBS listing for their products should monitor these schedules as they directly determine formulary placement. Healthcare providers and patients benefit from understanding which drugs fall under each formulary for cost and availability purposes.

What to do next

  1. Review current F1 and F2 drug listings for compliance
  2. Monitor for future amendments to the determination

Archived snapshot

Apr 14, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

- Interactions

National Health (Listed Drugs on F1 or F2) Determination 2021

In force Administered by
- Department of Health, Disability and Ageing
This item is authorised by the following title:


View document Legislative instrument Filter active Table of contents
- 1 Name
- 3 Authority
- 5 Definitions
- 6 Drugs on F1
- 7 Drugs on F2
- Schedule 1—Drugs on F1
- Schedule 2—Drugs on F2
- Endnotes
- Endnote 1—About the endnotes
- Endnote 2—Abbreviation key
- Endnote 3—Legislation history
- Endnote 4—Amendment history

Named provisions

Name Authority Definitions Drugs on F1 Drugs on F2 Schedule 1—Drugs on F1 Schedule 2—Drugs on F2

Get daily alerts for AU Federal Legislative Instruments (7-day)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from DoH (AU).

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
DoH (AU)
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
F2021L00390

Who this affects

Applies to
Pharmaceutical companies Healthcare providers Patients
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Pharmaceutical regulation Drug formulary listing PBS subsidy determination
Geographic scope
Australia AU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Regulatory Affairs
Topics
Healthcare Consumer Finance

Get alerts for this source

We'll email you when AU Federal Legislative Instruments (7-day) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!